000 | 01986 a2200565 4500 | ||
---|---|---|---|
005 | 20250517143915.0 | ||
264 | 0 | _c20170719 | |
008 | 201707s 0 0 eng d | ||
022 | _a1879-1891 | ||
024 | 7 |
_a10.1016/j.ajo.2017.03.001 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFardeau, Christine | |
245 | 0 | 0 |
_aInterferon-alpha2a and Systemic Corticosteroid in Monotherapy in Chronic Uveitis: Results of the Randomized Controlled BIRDFERON Study. _h[electronic resource] |
260 |
_bAmerican journal of ophthalmology _cMay 2017 |
||
300 |
_a182-194 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 | _aChronic Disease |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aFovea Centralis _xpathology |
650 | 0 | 4 |
_aGlucocorticoids _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunologic Factors _xadministration & dosage |
650 | 0 | 4 | _aInjections, Subcutaneous |
650 | 0 | 4 | _aInterferon alpha-2 |
650 | 0 | 4 |
_aInterferon-alpha _xadministration & dosage |
650 | 0 | 4 |
_aMacular Edema _xdiagnosis |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aRecombinant Proteins _xadministration & dosage |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTomography, Optical Coherence |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aUveitis, Posterior _xcomplications |
650 | 0 | 4 | _aVisual Acuity |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aSimon, Anne | |
700 | 1 | _aRodde, Benoît | |
700 | 1 | _aViscogliosi, Fabiana | |
700 | 1 | _aLabalette, Pierre | |
700 | 1 | _aLooten, Vincent | |
700 | 1 | _aTézenas du Montcel, Sophie | |
700 | 1 | _aLeHoang, Phuc | |
773 | 0 |
_tAmerican journal of ophthalmology _gvol. 177 _gp. 182-194 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ajo.2017.03.001 _zAvailable from publisher's website |
999 |
_c26989387 _d26989387 |